MedTrace Logo

The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery

NCT07561827 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-05-01

No results posted yet for this study

Summary

This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery.

The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.

Conditions

  • Adolescent Idiopathic Scoliosis (AIS)
  • Neuromuscular Scoliosis
  • Adolescent Idiopathic Scoliosis

Interventions

DRUG

Ropivacaine Hydrocloride

This drug is approved as a local anesthetic.

Sponsors & Collaborators

Principal Investigators

  • Ishaan Swarup, MD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-06
Primary Completion
2027-01-26
Completion
2027-01-26
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561827 on ClinicalTrials.gov